ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.574
Delayed Data
As of 4:01pm ET
 +0.004 / +0.70%
Today’s Change
0.53
Today|||52-Week Range
1.46
-21.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization3.6K20.4K45.8K50.4K
 
 
 
 
 
 
Operating ExpensesGross Income-3.6K-20.4K-45.8K-50.4K
 
 
 
 
 
General Expenses5.1M8.6M11.8M9.4M
 
 
 
 
 
Research And Development2.3M5.0M7.7M5.3M
 
 
 
 
 
Total Operating Expenses5.1M8.6M11.8M9.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.1M-8.6M-11.8M-9.5M
 
 
 
 
 
Extraordinary Credit0.002.9M0.00642.4K
 
 
 
Extraordinary Charge-1.0M0.00-2.3M0.00
 
 
 
Other Expenses0.000.00-397.3K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.2M-5.7M-14.5M-8.8M
 
 
 
 
 
Preferred Dividend-2.1M0.000.000.00
 
 
Net Income-6.2M-5.7M-14.5M-8.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.2M27.5M41.8M54.3M
 
 
 
 
 
Shares To Calculate EPS Diluted19.2M27.5M41.8M54.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.43-$0.21-$0.35-$0.16
 
 
 
 
 
EPS Diluted-$0.43-$0.21-$0.35-$0.16
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account